Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fortrea Holdings Inc. - Common Stock (NQ:FTRE)

8.835 -0.565 (-6.01%)
Streaming Delayed Price Updated: 11:43 AM EDT, Mar 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 373,847
Open 9.380
Bid (Size) 8.830 (5)
Ask (Size) 8.840 (3)
Prev. Close 9.400
Today's Range 8.420 - 9.450
52wk Range 8.650 - 40.63
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at West Pharmaceutical Services (NYSE:WST) and its peers. 
Via StockStory
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including Medpace (NASDAQ:MEDP) and its peers. 
Via StockStory

Performance

YTD
-52.6%
-52.6%
1 Month
-41.8%
-41.8%
3 Month
-52.9%
-52.9%
6 Month
-60.7%
-60.7%
1 Year
-77.0%
-77.0%

More News

Read More
Securities Fraud Investigation Into Fortrea Holdings Inc. (FTRE) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
Fortrea Holdings Inc. (FTRE) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
Securities Fraud Investigation Into Fortrea Holdings Inc. (FTRE) Continues – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
From Law Offices of Frank R. Cruz
Via Business Wire
FORTREA ALERT: Bragar Eagel & Squire, P.C. is Investigating Fortrea Holdings Inc. on Behalf of Fortrea Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)
Via StockStory
Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks
Via StockStory
Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks
Via StockStory
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack
Via StockStory
Securities Fraud Investigation Into Fortrea Holdings Inc. (FTRE) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
Fortrea Holdings Inc. (FTRE) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4
Via StockStory
Securities Fraud Investigation Into Fortrea Holdings Inc. (FTRE) Announced – Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
From Law Offices of Frank R. Cruz
Via Business Wire
Tesla Rebounds While Tariffs Weigh On Manufacturing: What's Driving Markets Monday?
Via Benzinga
Why Fortrea (FTRE) Shares Are Plunging Today
Via StockStory
Fortrea (NASDAQ:FTRE) Misses Q4 Revenue Estimates, Stock Drops
Via StockStory
Fortrea Reports Fourth Quarter and Full-Year 2024 Results; Issues Full-Year 2025 Guidance
From Fortrea Holdings Inc
Via GlobeNewswire
Earnings Scheduled For March 3, 2025
Via Benzinga
What To Expect From Fortrea’s (FTRE) Q4 Earnings
Via StockStory
Fortrea to Add Erin L. Russell to Board of Directors
From Fortrea Holdings Inc
Via GlobeNewswire
1 Healthcare Stock to Hold Forever and 2 to Ignore
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research
From Fortrea Holdings Inc
Via GlobeNewswire
Fortrea Announces Date for Fourth Quarter and Full Year 2024 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire

Frequently Asked Questions

Is Fortrea Holdings Inc. - Common Stock publicly traded?
Yes, Fortrea Holdings Inc. - Common Stock is publicly traded.
What exchange does Fortrea Holdings Inc. - Common Stock trade on?
Fortrea Holdings Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Fortrea Holdings Inc. - Common Stock?
The ticker symbol for Fortrea Holdings Inc. - Common Stock is FTRE on the Nasdaq Stock Market
What is the current price of Fortrea Holdings Inc. - Common Stock?
The current price of Fortrea Holdings Inc. - Common Stock is 8.835
When was Fortrea Holdings Inc. - Common Stock last traded?
The last trade of Fortrea Holdings Inc. - Common Stock was at 03/25/25 11:43 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.